Siren, L.L.C. Arrowhead Pharmaceuticals, Inc. Transaction History
Siren, L.L.C.
- $1.76 Trillion
- Q1 2025
A detailed history of Siren, L.L.C. transactions in Arrowhead Pharmaceuticals, Inc. stock. As of the latest transaction made, Siren, L.L.C. holds 2,669,880 shares of ARWR stock, worth $41 Million. This represents 1.94% of its overall portfolio holdings.
Number of Shares
2,669,880
Previous 2,901,681
7.99%
Holding current value
$41 Million
Previous $54.6 Billion
37.65%
% of portfolio
1.94%
Previous 2.41%
Shares
3 transactions
Others Institutions Holding ARWR
# of Institutions
300Shares Held
95.2MCall Options Held
306KPut Options Held
432K-
Black Rock Inc. New York, NY15.7MShares$241 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA13.2MShares$203 Million0.0% of portfolio
-
Avoro Capital Advisors LLC New York, NY11.1MShares$170 Million2.29% of portfolio
-
State Street Corp Boston, MA7MShares$107 Million0.0% of portfolio
-
Slate Path Capital LP New York, NY5.23MShares$80.3 Million1.32% of portfolio
About ARROWHEAD PHARMACEUTICALS, INC.
- Ticker ARWR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 105,849,000
- Market Cap $1.62B
- Description
- Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...